ALKS - MCAP CO - Alkermes plc

The price action of Alkermes plc (ALKS) serves as an indicator of success for the company, which generates revenue from the sale of unique treatments for alcoholism and psychiatric disorders, for which demand is growing due to the implementation of long-acting injections. The current market capitalization stands at 6.84. The business derives additional income from licensing fees for the use of its patented drug delivery methods by third-party organizations.

When constructing a long-term portfolio, screening by business size helps determine an asset's resilience to market volatility. The total market capitalization of Alkermes plc (ALKS), reflecting the company's market valuation, confirms its operational stability through the diversification of production across the US and EU, as clearly demonstrated by the issuer's capitalization trend.